AstraZeneca today announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused...
Read moreNovartis announced results from the head-to-head Phase III FIXTURE study showing secukinumab (AIN457), an interleukin-17A (IL-17A) inhibitor, was significantly superior...
Read moreResearchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous...
Read moreNovartis and Malaria No More announced today the debut of the Power of One campaign, encouraging people around the world...
Read moreGlaxoSmithKline (GSK) plc has announced a new four year contract with the Biomedical Advanced Research and Development Authority (BARDA), part...
Read moreAstraZeneca announced that MedImmune, its global biologics research and development arm, has entered into a definitive agreement to acquire Amplimmune,...
Read moreA new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins...
Read moreUncertainty persists regarding whether drugs that lower sugar reduce the risk of heart attack, with some concerns that diabetes drugs...
Read moreNovartis has invited 60 selected students from leading international universities in 21 countries to its headquarters in Switzerland for the...
Read moreThe European Medicines Agency (EMA) and the United States Food and Drug Administration (US FDA) have published a joint question-and-answer...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
